BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 28025657)

  • 21. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
    Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
    J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
    Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
    Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-9 limits hepatic fibrosis by suppressing the activation and proliferation of hepatic stellate cells by directly targeting MRP1/ABCC1.
    Sun J; Zhang H; Li L; Yu L; Fu L
    Oncol Rep; 2017 Mar; 37(3):1698-1706. PubMed ID: 28098912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NEAT1 accelerates the progression of liver fibrosis via regulation of microRNA-122 and Kruppel-like factor 6.
    Yu F; Jiang Z; Chen B; Dong P; Zheng J
    J Mol Med (Berl); 2017 Nov; 95(11):1191-1202. PubMed ID: 28864835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PU.1-deficient mice are resistant to thioacetamide-induced hepatic fibrosis: PU.1 finely regulates Sirt1 expression via transcriptional promotion of
    Liu Q; Zhang Y; Yang S; Wu Y; Wang J; Yu W; Liu Y
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29162670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-130a and -130b enhance activation of hepatic stellate cells by suppressing PPARγ expression: A rat fibrosis model study.
    Lu L; Wang J; Lu H; Zhang G; Liu Y; Wang J; Zhang Y; Shang H; Ji H; Chen X; Duan Y; Li Y
    Biochem Biophys Res Commun; 2015 Sep; 465(3):387-93. PubMed ID: 26255201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carnosol-mediated Sirtuin 1 activation inhibits Enhancer of Zeste Homolog 2 to attenuate liver fibrosis.
    Zhao H; Wang Z; Tang F; Zhao Y; Feng D; Li Y; Hu Y; Wang C; Zhou J; Tian X; Yao J
    Pharmacol Res; 2018 Feb; 128():327-337. PubMed ID: 29106960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
    Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
    Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ampelopsin attenuates carbon tetrachloride-induced mouse liver fibrosis and hepatic stellate cell activation associated with the SIRT1/TGF-β1/Smad3 and autophagy pathway.
    Ma JQ; Sun YZ; Ming QL; Tian ZK; Yang HX; Liu CM
    Int Immunopharmacol; 2019 Dec; 77():105984. PubMed ID: 31677501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
    Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
    J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
    [TBL] [Abstract][Full Text] [Related]  

  • 32.  MicroRNA-146b regulates hepatic stellate cell activation via targeting of KLF4.
    Ge S; Zhang L; Xie J; Liu F; He J; He J; Wang X; Xiang T
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):918-928. PubMed ID: 27740527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa_circ_0009096/miR-370-3p modulates hepatic stellate cell proliferation and fibrosis during biliary atresia pathogenesis.
    Wu Z; Wang B; Chen S; Zuo T; Zhang W; Cheng Z; Fu J; Gong J
    PeerJ; 2024; 12():e17356. PubMed ID: 38766485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
    Fu J; Wu B; Zhong S; Deng W; Lin F
    Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy.
    Chen J; Yu Y; Li S; Liu Y; Zhou S; Cao S; Yin J; Li G
    J Cell Mol Med; 2017 Dec; 21(12):3679-3692. PubMed ID: 28766848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Mediators Inflamm; 2016; 2016():9856538. PubMed ID: 27610008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beraprost sodium, a prostacyclin analogue, reduces fructose-induced hepatocellular steatosis in mice and in vitro via the microRNA-200a and SIRT1 signaling pathway.
    Zhang P; Xu L; Guan H; Liu L; Liu J; Huang Z; Cao X; Liao Z; Xiao H; Li Y
    Metabolism; 2017 Aug; 73():9-21. PubMed ID: 28732575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
    Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
    J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
    Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
    Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
    Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
    Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.